The U.S. Antibody Specificity Testing Market was valued at USD 364.63 million in 2024 and is projected to reach USD 729.09 million by 2034, growing at a CAGR of 7.2% during the forecast period. The market growth is driven by increasing adoption of monoclonal antibodies, expanding biopharmaceutical research, growing need for accurate diagnostic assays, and regulatory compliance...